Tvardi Therapeutics, Inc. (ticker: TVRD) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of TVRD's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. TVRD reported $2.57M in revenue and -$6.80M for the period ending 2025-03-31, with operating cash flow of -$5.86M. Cash and equivalents stood at $19.85M (down 42% year-over-year). Total assets of $25.82M exceed total liabilities of $11.31M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
TVRD Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Tvardi Therapeutics, Inc. (TVRD) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.